Inspire Medical price target lowered to $235 from $250 at Truist
Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 ...
Inspire Medical price target lowered to $220 from $230 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Inspire Medical (INSP) to $220 from $230 and keeps an Overweight rating on the shares. Though ...